Evaluation of Treatment Response With Integrated MRI/PET in Patients With Hepatocellular Carcinoma
The purpose of this study is to explore the ability of integrated MRI/PET to detect and evaluate treatment outcome in HCC patients.
Hepatocellular Carcinoma
DEVICE: The imaging biomarkers determined by MR-PET
The recurrence rate at 3 months after treatment, 3 months
The overall survival after treatment, 1 year
This study using 18F-FDG PET and functional MRI (DCE-MRI, Diffusion-weighted MRI, MR spectroscopy).